Even with BCR-ABL1 inhibition, hypoxic conditions of BMM induce CML cells survival through the activation of HIF-1 signaling pathway [27,199]. This evidence concerns the gene HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive.